Similar Items: Platelet–Prostate cancer crosstalk driving disparities and therapeutic vulnerabilities
- Multifactorial diagnostic model combining SAT-PCA3 in prostate cancer
- A case of primary prostatic intravascular large B-cell lymphoma misdiagnosed as benign prostatic hyperplasia
- Metformin in endometrial cancer from metabolic regulation to precision therapeutics
- Mean Platelet Volume in Hyperthyroid Toxic Adenoma Patients after Radioactive 131I Treatment
- The adenosine A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implications
- Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics